European Pharmaceutical Review

APRIL 17, 2024

In the rapid sterility testing industry, the membrane filtration segment dominated the market , the author stated. Leading players are investing “heavily” in R&D to expand their product lines and will contribute to growth of the market, the author shared. For example, this is due to demand for liquid formulations.

Dosage 83

Dosage Compounding 83

European Pharmaceutical Review

FEBRUARY 20, 2024

The authors also noted that growth of the upstream bioprocessing market is being pushed by the need for process improvement, and because “processing equipment consumption has expanded”.

Process Improvement 79

Process Improvement 79

European Pharmaceutical Review

APRIL 17, 2023

According to the authors of the report, clinical trials are a key driver of demand for automated solutions, due to the requirement of large quantities of high-quality drugs to be produced quickly and accurately. Sartorius Stedim Biotech SA, Siemens Healthineers and Thermo Fisher Scientific Inc.

Dosage 90

Dosage Compounding 90

European Pharmaceutical Review

JUNE 30, 2023

Additionally, growth of emerging markets in regions like Latin America and Asia-Pacific means that there is great potential for the market to expand, the authors wrote. Bruker Corporation Sartorius AG Repligen Corporation. Key players in the global PAT market include: PerkinElmer Inc. Thermo Fisher Scientific Inc.

Compounding 90

Compounding 90

European Pharmaceutical Review

AUGUST 22, 2023

Technology advancement According to the authors, over the past three years, several innovative bioprocess container-related products have been launched. Merck KGaA and Sartorius AG. Scalability is another challenge related to bioprocess containers, as this apparatus may need to be customised for specific applications. Lonza Group AG.,

87

87